Radiofrequency ablation in the treatment of liver metastases from colorectal cancer (Q24202637)

4

0 references

Stefano Trastulli

2

0 references

Iosief Abraha

8

0 references

author name string

Carlo Boselli

3

0 references

Davide Cavaliere

5

0 references

Amilcare Parisi

6

0 references

Giuseppe Noya

Cochrane Database of Systematic Reviews

7

0 references

publication date

13 June 2012

0 references

published in

0 references

cites work

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Solitary colorectal liver metastasis: resection determines outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Liver metastases of colorectal carcinoma--may the DRG-system influence the operative procedure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation of liver tumors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

[Radiofrequency ablation for treatment of metastatic colorectal carcinoma: state of the art despite of missing randomized trials?].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation of liver tumours: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Systematic Reviews in Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Interstitial ablative techniques for hepatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation of liver metastases from colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Guidelines for resection of colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radio-frequency ablation of colorectal liver metastases in 167 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Hepatic ablation using bipolar radiofrequency electrocautery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Quality of reporting of observational longitudinal research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Percutaneous cryosurgery for the treatment of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

A general parametric approach to the meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Radiofrequency ablation for resectable colorectal hepatic metastases: is it time for a randomized controlled trial?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006317.PUB3

7 January 2021

10.1002/14651858.CD006317.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4620972

OpenCitations bibliographic resource ID

4620972

1 reference